Navigation Links
Elecsys 1010 System

ProductsElecsys 1010 System
Company Roche Diagnostics
Item Elecsys 1010 System
Features Benchtop analyzer, multiple sizes and types of sample containers. Stat samples can be introduced into normal routine operation at any time and are assigned the highest priority for processing. Various dilution ratios can be selected for each sample and the Elecsys systems perform the dilution automatically. Reagents are identified and inventory is tracked on the system automatically through the use of information rich two-dimensional barcodes. Innovative barcoding system for reagents, calibrators and controls offers large data capacity and high security, permitting programming by loading (PBL). Liquid level and clot detection: facilitate trouble-free testing. Bi-directional interfacing: enables easy data transfer and lab integration.
Description Engineered for small and medium volume laboratories, as well as specialty labs, the Elecsys 1010 System offers the speed, simplicity and flexibility needed to respond to multiple testing requirements. Compact yet powerful, the Elecsys 1010 system enables operators to handle everything from rapid response assays to routine testing without sacrificing ease of operation or cost efficiency. An ideal Stat system, the Elecsys 1010 provides fast result turnaround. In pregnancy screening, the remarkably broad HCG detection range of 0.5-10,000 mIU/ml ensures exceptional accuracy. Eliminating the need for a high percentage of re-runs and dilutions also results in significant time and cost savings.
Info Roche DiagnosticsCall Roche Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-415-6694

Customer Service: 1-800-428-5074
Web site: http://www.roche-diagnostics.com

Related medicine products :

1. Elecsys 2010 Rack System
2. Elecsys 2010 Disk System
3. Elecsys® proBNP
4. Silicone Oil Cannula System - 20 Gauge
5. Silicone Oil Cannula System - 19 Gauge
6. SuperVu Galilean System
7. KOWA nonmyd 7 / VK-2 Digital Imaging System
8. KOWA nonmyd a-D / VK-2 Digital Imaging System
9. Refraction System RT-2100
10. Odyssey Phacoemulsification System
11. SIStem Phacoemulsification System
Marlin' Cervical Orthosis ensures comfort and immobilization with its semirigid molded polyethylene anterior frame and occipital component. Two-piece design allows free air flow and easy application.
Exo-Deluxe Overhead Traction for hospital or home care. Twice the clearance of other units between the patient and supporting wall. 2" nylon pulleys with polypropylene cord, head halter, spreader bar
...e Relief Padding&trade is perfect for use for ligh...terials or used to line braces, prosthetics, ortho...nst shock and vibration and conforms to all body c...g and chaffing. It is a 2mm thick gel sheet with a...
This lightweight, full length 10" elastic binder has a variety of applications. Its most common use is as an abdominal binder for post-surgical dressings. It is effective in supporting abdominal co
Medicine Products:
(Date:7/25/2008)...weight or obese is not only a personal issue that ...ssue that impacts other people in society. A new s...eals that the extra Medicare cost associated with ...t financial burden on tax payers, costing up to hu...rrent Medicare population. , The article,s find...
(Date:7/25/2008)...ers tips and encourages them to, ,Speak Up,(TM) f... 25 /PRNewswire-USNewswire/ -- The Pennsylvania,Pa...tient Safety Day" which,is a national effort to en... fully in their healthcare by asking questions and...or illness., "We understand the important role th...
(Date:7/25/2008)...ber of jobs created in the medical field slowed in...nt kind of slowdown: they laid off fewer people in... Seattle, WA (PRWEB) July 25, 2008 -- Thoug...slowed in June overall, pharmaceutical companies r...music to the ears of sales representatives: fewer ...
(Date:7/25/2008)... of Defense and Federal Agencies in, the executio...oenix is a, four-day, multi-agency collaborative... and local agencies with large and complex inciden...ital, ad-hoc, secure mobile communications infra...ORFOLK, Va., July 25 /PRNewswire/ -- Dataline LLC ...
Breaking Medicine News(10 mins):Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3
...e improvement in patients who undergo yoga program...y proving the age-old belief about the interrelati...nsiderable improvement in the quality of life of t...ga program than those who do not. The study, prese...
...f Disease in Childhood says ‘Low birthweight babie...become hyperactive and with low attention spans’ a...ntion span, and impulsive behaviour characterise t...er, or HKD for short. It is one of the most common...
...ntification of a starter hormone responsible for i...moths//. The research was led by David Champlin, ...Maine, and assisted by students Paul Allee of Port...hree colleagues who are professors at the Universi...
...ologist and brain injury expert died on Wednesday ... standards to determine whether a patient was in a...his family the cause of death was complications of...rd had long been an advocate for the right of term...
Other Medicine News:Health News:Yoga Along with Treatment for Breast Cancer Improves Quality of Life 2Health News:Yoga Along with Treatment for Breast Cancer Improves Quality of Life 3Health News:Hormone Transforming Caterpillars to Moths Identified 2Health News:Renowned Doctor Passes Away 2
(Date:7/22/2008)...Latest awards under Therapeutics Development Initi...rations to 23; next deadline January 20,2009, NE... of its mission to,speed delivery of transformativ...he Michael J. Fox Foundation for Parkinson,s Resea...ix industry research teams. The awards,were grante...
(Date:7/22/2008)...wo Regimens Including Lantus(R) and Apidra(R) Resu... with Type 2 Diabetes, Whatever the Algorithm ....J., July 22 /- Results from the "Adj...Simple Algorithm to Carbohydrate,Counting for Adju...published in the American Diabetes Association,s (...
(Date:7/22/2008)... Developed and Validated by Columbia University Me...Proprietary MicroRNA Technology, The Test Differ... Lung Cancer (NSCLC), Classifying Squamous-Cell C... Percent and Specificity of 90 Percent,This is the...s, Sensitivity as Biomarkers for Accurate...
(Date:7/22/2008)...Pilot Study Suggests That Ekkyo,s New Approach of ...ally Improve Scar Healing Physiology, MARSEILLES,...nown as,Heatwave Technology) a photomedicine compa...ems for skin scar prevention and reduction, announ...in Lasers in Surgery and Medicine*,reporting the r...
Breaking Medicine Technology:Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3Center for Poverty Research to study senior hunger in America 2387 1Center for Poverty Research to study senior hunger in America 2387 2Weight Loss Can Control Hypertension 2385 1Weight Loss Can Control Hypertension 2385 2Weight Loss Can Control Hypertension 2385 3National Trichotillomania Awareness Week Gives Help and Hope to Hair Pullers 2382 1National Trichotillomania Awareness Week Gives Help and Hope to Hair Pullers 2382 2Connecticut Bishops Back Down over Provision of Emergency Contraception 2379 1Connecticut Bishops Back Down over Provision of Emergency Contraception 2379 2
...mbination Therapy Significantly Decreased Tumor Bl...e Tumors -, LOS ANGELES and TUSTIN, Calif., April ...aceuticals, Inc. , a,clinical stage biopharmaceuti...ies for the treatment of cancer and hepatitis C,vi...cal data,presented at the Centennial Annual Meetin...
...GARY, April 17, 2007 /PRNewswire-FirstCall/ - Onco...a poster by Dr. Maureen,E. Lane et al. of , New Yo...ovirus and Gemcitabine in Ras-Mutated Human HCT116... the American,Association for Cancer Research (AAC...runs from April 14-18, 2007. , The researchers fou...
Other Medicine Technology:Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 2Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 3Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 4Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 5Oncolytics Biotech Inc. Research Collaborators Demonstrate,Reovirus/Gemcitabine Combination Has Synergistic Effect Against,Human Colon Cancer Cell Lines 2Oncolytics Biotech Inc. Research Collaborators Demonstrate,Reovirus/Gemcitabine Combination Has Synergistic Effect Against,Human Colon Cancer Cell Lines 3